Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis

Nature Medicine

Volumn 19, Issue 2, 2013, Pages 227-231

  LeBleu, Valerie S ^a   Teng, Yingqi ^a   O'Connell, Joyce T ^a   Charytan, David ^b   Müller, Gerhard A ^c   Müller, Claudia A ^c   Sugimoto, Hikaru ^a   Kalluri, Raghu ^a,d,e,f  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; HUMAN EPIDIDYMIS PROTEIN 4; MATRIX METALLOPROTEINASE; PRSS23 ENZYME; PRSS35 ENZYME; SERINE PROTEINASE; UNCLASSIFIED DRUG; PROTEIN; WFDC2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL LINE; FIBROBLAST; FIBROSIS; HUMAN; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL LINE; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; PROTEINS;

EID: 84873570970     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2989     Document Type: Article

References (32)

1. Zeisberg, M., Strutz, F. & Muller, G.A. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol. 13 (suppl. 3), S111-S120 (2000).
2. Eddy, A.A. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7, 2495-2508 (1996).
3. Strutz, F. & Muller, G.A. Renal fibrosis and the origin of the renal fibroblast. Nephrol. Dial. Transplant. 21, 3368-3370 (2006).
4. Okada, H., Strutz, F., Danoff, T.M., Kalluri, R. & Neilson, E.G. Possible mechanisms of renal fibrosis. Contrib. Nephrol. 118, 147-154 (1996).
5. Zeisberg, M. & Neilson, E.G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 21, 1819-1834 (2010).
6. Meran, S. & Steadman, R. Fibroblasts and myofibroblasts in renal fibrosis. Int. J. Exp. Pathol. 92, 158-167 (2011).
7. Barnes, J.L. & Glass, W.F. II. Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts. Contrib. Nephrol. 169, 73-93 (2011).
8. Grgic, I., Duffield, J.S. & Humphreys, B.D. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr. Nephrol. 27, 183-193 (2012).
9. Kirchhoff, C. Molecular characterization of epididymal proteins. Rev. Reprod. 3, 86-95 (1998).
10. Kirchhoff, C., Habben, I., Ivell, R. & Krull, N. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol. Reprod. 45, 350-357 (1991).
11. Hahm, K. et al. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am. J. Pathol. 170, 110-125 (2007).
12. Zhang, G. et al. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J. Am. Soc. Nephrol. 14, 1254-1271 (2003).
13. Bingle, L., Singleton, V. & Bingle, C.D. The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 21, 2768-2773 (2002).
14. Clauss, A., Lilja, H. & Lundwall, A. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem. J. 368, 233-242 (2002).
15. Clauss, A., Lilja, H. & Lundwall, A. The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochem. Biophys. Res. Commun. 333, 383-389 (2005).
16. Bingle, L. et al. WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir. Res. 7, 61 (2006).
17. Greer, K.A. et al. Gene expression analysis in a canine model of X-linked Alport syndrome. Mamm. Genome 17, 976-990 (2006).
18. Bielesz, B. et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J. Clin. Invest. 120, 4040-4054 (2010).
19. Bunnag, S.a. Molecular correlates of renal functions in kidney transplant biopsies. J. Am. Soc. Nephrol. 20, 1149-1160 (2009).
20. Galgano, M.T., Hampton, G.M. & Frierson, H.F. Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod. Pathol. 19, 847-853 (2006).
21. Sivashanmugam, P. et al. Characterization of mouse Eppin and a gene cluster of similar protease inhibitors on mouse chromosome 2. Gene 312, 125-134 (2003).
22. Bignotti, E. et al. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. Br. J. Cancer 104, 1418-1425 (2011).
23. Drapkin, R. et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 65, 2162-2169 (2005).
24. Matsuo, S. et al. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int. 67, 2221-2238 (2005).
25. Oda, T. et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int. 60, 587-596 (2001).
26. Catania, J.M., Chen, G. & Parrish, A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am. J. Physiol. Renal Physiol. 292, F905-F911 (2007).
27. Zeisberg, M. et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J. Physiol. Renal Physiol. 285, F1060-F1067 (2003).
28. Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544-550 (2010).
29. Panicker, L.M., Usha, R., Roy, S. & Mandal, C. Purification and characterization of a serine protease (CESP) from mature coconut endosperm. BMC Res. Notes 2, 81 (2009).
30. LeBleu, V.S., Sugimoto, H., Miller, C.A., Gattone, V.H. II & Kalluri, R. Lymphocytes are Dispensable for Glomerulonephritis but Required for Renal Interstitial Fibrosis in Matrix Defect Induced Alport Renal Disease. Lab. Invest. 88, 284-292 (2008).
31. Lebleu, V.S. et al. Stem Cell Therapies Benefit Alport Syndrome. J. Am. Soc. Nephrol. 20, 2359-2370 (2009).
32. Sugimoto, H. et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat. Med. 18, 396-404 (2012)